INTERNATIONAL PATENT: SECARNA PHARMACEUTICALS GMBH & CO. KG FILES APPLICATION FOR "MLKL-SPECIFIC ANTISENSE OLIGONUCLEOTIDES AND THEIR USE IN THE PREVENTION AND/OR TREATMENT OF A DISORDER CAUSED BY FORMS OF CELL DEATH SUCH AS NECROPTOSIS"

GENEVA, July 10 -- SECARNA PHARMACEUTICALS GMBH & CO. KG (Rudolf-Bultmann-Str. 4h35039 Marburg) filed a patent application (PCT/EP2024/088573) for "MLKL-SPECIFIC ANTISENSE OLIGONUCLEOTIDES AND THEIR USE IN THE PREVENTION AND/OR TREATMENT OF A DISORDER CAUSED BY FORMS OF CELL DEATH SUCH AS NECROPTOSIS" on Dec 27, 2024. With publication no. WO/2025/141163, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PETRUSCHKE, Julia (c/o Rudolf-Bultmann-Str. 4h35039 Marburg), KLAR, Richard (c/o Rudolf-Bultmann-Str. 4h35039 Marburg), MI...